
ASGN (ASGN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
968.3M
Gross Profit
275.4M
28.44%
Operating Income
46.6M
4.81%
Net Income
20.9M
2.16%
EPS (Diluted)
$43.70
Balance Sheet Metrics
Total Assets
3.7B
Total Liabilities
1.9B
Shareholders Equity
1.8B
Debt to Equity
1.06
Cash Flow Metrics
Operating Cash Flow
28.9M
Free Cash Flow
6.6M
Revenue & Profitability Trend
ASGN Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.1B | 4.5B | 4.6B | 4.0B | 3.5B |
Cost of Goods Sold | 2.9B | 3.2B | 3.2B | 2.9B | 2.6B |
Gross Profit | 1.2B | 1.3B | 1.4B | 1.1B | 947.2M |
Gross Margin % | 28.9% | 28.8% | 29.9% | 28.5% | 27.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 821.2M | 844.2M | 895.0M | 735.8M | 615.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 821.2M | 844.2M | 895.0M | 735.8M | 615.0M |
Operating Income | 304.4M | 364.1M | 409.5M | 350.9M | 281.2M |
Operating Margin % | 7.4% | 8.2% | 8.9% | 8.8% | 8.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 64.3M | 66.4M | 45.9M | 37.5M | 39.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 240.1M | 297.7M | 363.6M | 313.4M | 241.5M |
Income Tax | 64.9M | 78.4M | 96.7M | 81.6M | 63.9M |
Effective Tax Rate % | 27.0% | 26.3% | 26.6% | 26.0% | 26.5% |
Net Income | 175.2M | 219.3M | 268.1M | 409.9M | 200.3M |
Net Margin % | 4.3% | 4.9% | 5.9% | 10.2% | 5.7% |
Key Metrics | |||||
EBITDA | 400.7M | 464.4M | 500.9M | 440.5M | 370.9M |
EPS (Basic) | $3.88 | $4.54 | $5.30 | $7.78 | $3.80 |
EPS (Diluted) | $3.83 | $4.50 | $5.23 | $7.66 | $3.76 |
Basic Shares Outstanding | 45200000 | 48300000 | 50600000 | 52700000 | 52700000 |
Diluted Shares Outstanding | 45200000 | 48300000 | 50600000 | 52700000 | 52700000 |
Income Statement Trend
ASGN Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 205.2M | 175.9M | 70.3M | 529.6M | 274.4M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 650.8M | 741.5M | 853.6M | 708.2M | 602.8M |
Inventory | - | - | - | - | - |
Other Current Assets | 17.1M | 19.1M | 17.3M | 30.4M | 17.3M |
Total Current Assets | 917.7M | 973.3M | 981.1M | 1.3B | 994.4M |
Non-Current Assets | |||||
Property, Plant & Equipment | 61.9M | 64.2M | 51.1M | 57.1M | 73.0M |
Goodwill | 4.2B | 4.3B | 4.4B | 3.6B | 3.3B |
Intangible Assets | 439.8M | 497.9M | 569.6M | 487.9M | 469.9M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 33.9M | 33.7M | 25.6M | 23.9M | 265.1M |
Total Non-Current Assets | 2.5B | 2.6B | 2.6B | 2.2B | 2.3B |
Total Assets | 3.4B | 3.5B | 3.6B | 3.5B | 3.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 27.2M | 34.0M | 35.2M | 20.1M | 38.3M |
Short-term Debt | 19.5M | 19.5M | 22.9M | 23.3M | 24.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 102.4M | 104.1M | 98.7M | 102.0M | 115.1M |
Total Current Liabilities | 367.1M | 394.1M | 441.9M | 450.9M | 416.2M |
Non-Current Liabilities | |||||
Long-term Debt | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
Deferred Tax Liabilities | 187.5M | 156.0M | 129.2M | 89.0M | 108.5M |
Other Non-Current Liabilities | 17.3M | 16.7M | 14.4M | 23.4M | 65.9M |
Total Non-Current Liabilities | 1.3B | 1.3B | 1.2B | 1.2B | 1.3B |
Total Liabilities | 1.7B | 1.7B | 1.7B | 1.6B | 1.7B |
Equity | |||||
Common Stock | 400.0K | 500.0K | 500.0K | 500.0K | 500.0K |
Retained Earnings | 1.1B | 1.2B | 1.2B | 1.2B | 926.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.8B | 1.9B | 1.9B | 1.9B | 1.6B |
Key Metrics | |||||
Total Debt | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
Working Capital | 550.6M | 579.2M | 539.2M | 858.5M | 578.2M |
Balance Sheet Composition
ASGN Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 175.2M | 219.3M | 268.1M | 409.9M | 200.3M |
Depreciation & Amortization | 96.3M | 100.3M | 91.4M | 89.6M | 89.7M |
Stock-Based Compensation | 42.3M | 44.0M | 49.3M | 52.7M | 32.3M |
Working Capital Changes | 71.2M | 102.2M | -154.0M | -177.4M | 76.6M |
Operating Cash Flow | 425.1M | 503.0M | 294.5M | 144.5M | 406.1M |
Investing Activities | |||||
Capital Expenditures | -35.3M | -39.9M | -37.5M | -34.7M | -32.6M |
Acquisitions | 0 | 0 | -474.8M | 281.0M | -186.2M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -35.3M | -40.5M | -510.0M | 246.5M | -219.0M |
Financing Activities | |||||
Share Repurchases | -327.2M | -273.1M | -281.4M | -181.3M | -27.9M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 0 | 571.8M | 94.0M | 0 | 65.5M |
Debt Repayment | -5.0M | -596.6M | -62.5M | 0 | -65.5M |
Financing Cash Flow | -350.4M | -329.8M | -275.4M | -198.7M | -41.1M |
Free Cash Flow | 364.7M | 417.0M | 270.3M | 159.0M | 392.2M |
Net Change in Cash | 39.4M | 132.7M | -490.9M | 192.3M | 146.0M |
Cash Flow Trend
ASGN Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.40
Forward P/E
9.82
Price to Book
1.30
Price to Sales
0.60
PEG Ratio
9.82
Profitability Ratios
Profit Margin
3.50%
Operating Margin
6.65%
Return on Equity
7.71%
Return on Assets
4.52%
Financial Health
Current Ratio
2.37
Debt to Equity
66.33
Beta
0.98
Per Share Data
EPS (TTM)
$3.12
Book Value per Share
$41.71
Revenue per Share
$90.92
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
asgn | 2.4B | 17.40 | 1.30 | 7.71% | 3.50% | 66.33 |
International | 245.2B | 42.38 | 8.91 | 22.67% | 9.11% | 245.47 |
Accenture plc | 174.0B | 22.22 | 5.69 | 26.93% | 11.61% | 25.88 |
Epam Systems | 9.6B | 23.69 | 2.63 | 11.57% | 8.47% | 4.34 |
Kyndryl Holdings | 8.9B | 36.67 | 7.28 | 20.54% | 1.67% | 297.00 |
Parsons | 8.0B | 31.93 | 3.27 | 13.26% | 3.86% | 54.68 |
Financial data is updated regularly. All figures are in the company's reporting currency.